3 Recruiting Myeloma Multiple Phase 2 Clinical Trials
Active phase 2 studies for myeloma multiple enrolling across the USA. Verify eligibility and contact site coordinators.
All Myeloma Multiple studiesPhase 2 Studies for Myeloma Multiple
🔵 Active, Not Recruiting Phase2
Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure
📍 Alaska Oncology and Hematology LLC — Anchorage, Alaska
View Study & Checklist ➔ 🟢 Recruiting Phase2
Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2
Limited-duration Teclistamab
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
View Study & Checklist ➔